Cinven’s Bioclinica weighs divestiture of CCBR unit

Cinven, Bioclinica, healthcare, clinical trial, private equity, merger, M&A
Yuri_Arcurs/DigitalVision/Getty Images
CCBR, the clinical research site unit of Cinven-backed Bioclinica, is up for sale, according to four sources. Rothschild is providing sell-side financial advice on the process, some of the sources said. CCBR operates a global network of research centers in ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.